This article describes the compatibility of two semicrystalline polymers, poly(ε-caprolactone) (PCL) and poly(l-lactic acid) (PLLA). The compatibility of the PCL/PLLA blends was enhanced by the compatibilizing effect of the poly(l,l-lactide-co-ε-caprolactone) [P(lLA-co-εCL)]. A discussion details the effect of the concentration of the compatibilizing agent, the copolymer of l,l-lactide and ε-caprolactone of a 50/50 mol ratio [P(lLA-co-εCL)], on the compatibility and the crystallization behavior of the blends of PCL and PLLA. It was found that the addition of P(lLA-co-εCL) could suppress the crystallization of PLLA at its Tc and induced the concurrent crystallization of PLLA and PCL.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2000) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: